Health

Ahmedabad based La Renon Healthcare developed a proprietary technology by the name of MPFAITECH and was able to address the aforesaid concerns with the endogenous amide exogenous supplementation and became the first company in the world to show to synergistic action of the amide with a natural FAAH inhibitor. They launched their product under the name PALMIGES in 2018 and at present have more than 40,000 Indian patients on the innovative product.

The World Health Organisation last year lauded India’s progress in reducing the MMR saying the progress puts the country on track towards achieving the Sustainable Development Goal (SDG) target of an MMR below 70 by 2030.

Speaking on the occasion, Shri Naik lauded success of the CRIUM in the treatment of vitiligo and other chronic and stubborn diseases and said that it’s perhaps the only medical institution in the world which has treated more than 1.5 lakh patients of Vitiligo alone.

Pretomanid is an important drug for the treatment of highly drug-resistant TB (DR-TB), if taken along with other TB medicines. It is also the third new anti-TB drug approved by USFDA in over 40 years. Significantly, Macleods has now become the second generic manufacturer for the drug, globally, after the TB Alliance earlier granted rights to US drug maker Mylan in August this year.